… This study indicated Simnotrelvir/Ritonavir and Nirmatrelvir/Ritonavir were more potent in
shortening the hospital stay of hospitalized patients with COVID-19 compared to Azvudine …

… have been developed, among which nirmatrelvir–ritonavir is highly recommended. We
intended to assess the effectiveness and safety of nirmatrelvir–ritonavir in the elderly mild-to-…

… Included patients had a positive SARS-CoV-2 test or nirmatrelvir–ritonavir … a
nirmatrelvir–ritonavir order. We propensity score matched patients treated with nirmatrelvir–ritonavir …

… the safety and efficacy of nirmatrelvir/ritonavir in preventing severe … , and the efficacy of
nirmatrelvir/ritonavir is evaluated in a … the impact of nirmatrelvir/ritonavir and determine strategy …

… Despite the reported benefits of nirmatrelvir-ritonavir, greater health care provider awareness
is required because many at-risk individuals are not being offered this important treatment …

… Information about the residential settings of patients, such as whether they resided in nursing
homes or other residential care settings, was not included in the dataset. Nonetheless, our …

… ), blocking the viral assembly; ritonavir acts as a pharmacologic booster of nirmatrelvir,
inhibiting the CYP3A4 enzyme in order to maintain high plasmatic levels of nirmatrelvir itself [7]. …

… patients treated with nirmatrelvir–ritonavir than in untreated patients is currently a question
of clinical interest. This observational study in a multicenter health care system compared the …

… In this retrospective cohort study, we sought to compare the effectiveness of sotrovimab,
molnupiravir, and nirmatrelvir-ritonavir in preventing hospital admission and death in higher-risk …

… world effectiveness of nirmatrelvir/ritonavir to prevent severe … We compared nirmatrelvir/ritonavir
treated patients to … days was lower in the nirmatrelvir/ritonavir treated group compared to …